Omeros Competitors

Stocks . Germany . 
Stock . Omeros
3O8 Stock  EUR 7.19  0.85  10.57%   
Omeros competes with ELECTRONIC ARTS, NIPPON STEEL, RELIANCE STEEL, TT Electronics, and ARROW ELECTRONICS; as well as few others. The company classifies itself under Healthcare sector and is part of Biotechnology industry. Analyzing Omeros competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Omeros to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Omeros Correlation with its peers.
For more detail on how to invest in Omeros Stock please use our How to Invest in Omeros guide.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Omeros competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.367.1917.57
Details
Intrinsic
Valuation
LowRealHigh
0.356.9617.34
Details
Naive
Forecast
LowNextHigh
0.073.6113.98
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
6.559.4212.30
Details

Omeros Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Omeros and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Omeros and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Omeros does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
RS6
+ 0.93
ERT
USX1
+ 0.73
RS6
USX1
+ 0.66
ERT
ME5A
+ 0.59
7TT
7TT
+ 0.46
ERT
ME5A
+ 0.37
NPSA
  
High negative correlations   
ARW
- 0.61
ERT
ARW
- 0.52
RS6
USX1
- 0.38
ARW
USX1
- 0.33
NPSA
ARW
- 0.16
7TT
ME5A
- 0.12
USX1

Risk-Adjusted Indicators

There is a big difference between Omeros Stock performing well and Omeros Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Omeros' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

Omeros Competitive Analysis

The better you understand Omeros competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Omeros' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Omeros' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
3O8 ERT NPSA RS6 7TT ARW USX1 ME5A
 10.57 
 7.19 
Omeros
 0.06 
 155.18 
ELECTRONIC
 0.82 
 6.15 
NIPPON
 3.77 
 278.10 
RELIANCE
 3.10 
 1.25 
7TT
 2.56 
 114.00 
ARROW
 2.00 
 32.30 
United
 1.65 
 12.30 
METHODE
Market Volatility
(90 Days Market Risk)
Risky
Very steady
Not too volatile
Very steady
Extremely Dangerous
Very steady
Very steady
Somewhat reliable
Market Performance
(90 Days Performance)
Good
Solid
Insignificant
OK
Insignificant
Very Weak
Very Weak
OK
Odds of Financial Distress
(Probability Of Bankruptcy)
Above Average
Low
Quite High
Low
Low
Low
Low
Low
Current Valuation
(Equity Enterprise Value)
Fairly Valued
Over Valued
Fairly Valued
Fairly Valued
Over Valued
Over Valued
Under Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Sell
Sell
Hold
Strong Hold
Strong Sell
Strong Sell
Cautious Hold
Cautious Hold
Current Ratio
1.73 X
N/A
1.51 X
N/A
N/A
N/A
1.27 X
N/A
Net Asset
419.27 M
13.8 B
N/A
10.33 B
671.4 M
21.76 B
19.46 B
1.39 B
Profit Margin
N/A
N/A
0.09 %
N/A
N/A
N/A
0.12 %
N/A
EBITDA
(170.49 M)
1.62 B
1.14 T
2.73 B
N/A
2.26 B
4.21 B
174.6 M
Operating Margin
5.54 %
N/A
0.11 %
N/A
N/A
N/A
0.16 %
N/A
Current Valuation
233.4 M
32.69 B
N/A
12.52 B
529.77 M
9.49 B
6.32 B
1.68 B
Price To Book
8.23 X
4.46 X
N/A
1.70 X
0.83 X
1.25 X
0.59 X
1.88 X
Five Year Return
N/A
N/A
N/A
N/A
N/A
N/A
0.87 %
N/A
Beta
1.18
N/A
1.45
N/A
N/A
N/A
2.16
N/A
Number Of Employees
213
N/A
106.53 K
N/A
N/A
N/A
22.74 K
N/A
Shares Outstanding
62.73 M
N/A
2.76 B
N/A
N/A
N/A
226.6 M
N/A
Cash Flow From Operations
(109.72 M)
1.9 B
403.19 B
2.12 B
N/A
(33.08 M)
3.5 B
98.8 M
Annual Yield
N/A
N/A
0.07 %
0.02 %
0.02 %
N/A
0.01 %
0.01 %
Total Debt
313.46 M
1.88 B
2.56 T
1.14 B
147.1 M
3.18 B
3.91 B
197.5 M
Return On Equity
N/A
N/A
0.19
N/A
N/A
N/A
0.26
N/A
Z Score
N/A
9.6
N/A
5.2
1.8
2.2
1.6
4.2
Return On Asset
-0.36
N/A
0.0579
N/A
N/A
N/A
0.11
N/A
Book Value Per Share
(0.74) X
N/A
1,430 X
N/A
N/A
N/A
44.74 X
N/A
Total Asset
419.27 M
13.8 B
N/A
10.33 B
671.4 M
21.76 B
19.46 B
1.39 B
Debt To Equity
902.60 %
N/A
0.82 %
N/A
N/A
N/A
0.97 %
N/A
Target Price
34.63
N/A
N/A
N/A
N/A
N/A
35.65
N/A
Last Dividend Paid
N/A
N/A
180.0
N/A
N/A
N/A
0.2
0.11
Shares Owned By Institutions
32.61 %
N/A
0.01 %
N/A
N/A
N/A
74.60 %
N/A
Market Capitalization
209.78 M
31.46 B
17.53 B
8.78 B
502.77 M
7.8 B
6.86 B
1.44 B
Price To Earning
(8.00) X
N/A
N/A
N/A
N/A
N/A
2.68 X
N/A
Price To Earnings To Growth
N/A
0.87 X
N/A
N/A
N/A
0.89 X
N/A
N/A
Price To Sales
4.82 X
4.87 X
N/A
0.71 X
0.59 X
0.20 X
0.24 X
1.48 X
Net Income
194.24 M
789 M
(32.43 B)
1.84 B
N/A
1.43 B
2.52 B
102.2 M
Earnings Per Share
(2.63) X
N/A
1.64 X
N/A
N/A
N/A
8.63 X
N/A
Shares Owned By Insiders
4.03 %
N/A
N/A
N/A
N/A
N/A
1.12 %
N/A
Revenue
N/A
6.99 B
7.52 T
17.02 B
N/A
37.12 B
21.07 B
1.16 B
Cash And Equivalents
47.22 M
N/A
387.24 B
N/A
N/A
N/A
1.33 B
N/A
Cash Per Share
0.96 X
N/A
N/A
N/A
N/A
N/A
4.92 X
N/A
Gross Profit
(71.4 M)
N/A
1.22 T
N/A
N/A
3.36 B
4.35 B
N/A
Day Typical Price
7.46
155.18
6.15
281.37
1.26
115.0
32.3
12.3
Accumulation Distribution
0.1
N/A
N/A
0.034
0.0234
0.0256
N/A
N/A
Market Facilitation Index
0.81
N/A
N/A
9.8
0.03
3.0
N/A
N/A
Daily Balance Of Power
(1.05)
(9,223,372,036,855)
9.2 T
(1.11)
(1.33)
(1.00)
(9,223,372,036,855)
9.2 T
Period Momentum Indicator
(0.85)
(0.10)
0.05
(10.90)
(0.04)
(3.00)
(0.66)
0.2
Rate Of Daily Change
0.89
1.0
1.01
0.96
0.97
0.97
0.98
1.02
Day Median Price
7.6
155.18
6.15
283.0
1.27
115.5
32.3
12.3
Price Action Indicator
(0.83)
(0.05)
0.025
(10.35)
(0.04)
(3.00)
(0.33)
0.1
Relative Strength Index
91.33
68.54
48.24
75.4
86.76
54.18
51.19
61.45
Coefficient Of Variation
680.83
438.46
2020.18
938.17
(2,403)
4294.56
21048.1
878.22
Mean Deviation
5.16
0.9241
0.9176
1.08
2.67
1.44
1.77
3.09
Jensen Alpha
1.41
0.2666
0.0194
0.0666
(0.16)
0.0324
(0.05)
0.5103
Total Risk Alpha
0.2247
0.1152
(0.11)
(0.04)
(0.98)
(0.24)
(0.32)
(0.06)
Sortino Ratio
0.2687
0.1739
(0.03)
0.0496
N/A
(0.02)
(0.04)
0.1264
Downside Variance
28.13
1.01
1.63
2.01
N/A
8.32
5.5
12.93
Standard Deviation
10.38
1.21
1.28
1.6
5.83
2.32
2.58
4.87
Kurtosis
17.02
2.33
2.05
5.34
20.64
11.37
3.21
11.79
Potential Upside
7.5
1.88
2.34
2.05
3.57
2.59
3.97
7.69
Treynor Ratio
1.32
(14.97)
0.1418
0.1541
0.2331
0.3411
0.0038
1.43
Maximum Drawdown
73.97
6.85
6.98
9.87
37.54
17.17
17.91
36.12
Variance
107.8
1.45
1.63
2.56
34.03
5.38
6.66
23.72
Market Risk Adjusted Performance
1.33
(14.96)
0.1518
0.1641
0.2431
0.3511
0.0138
1.44
Risk Adjusted Performance
0.1158
0.1694
0.0402
0.0828
(0.02)
0.0238
0.0106
0.0911
Skewness
3.62
0.6999
0.9503
1.03
(0.36)
(1.54)
0.1839
2.48
Semi Deviation
4.33
0.7748
0.8996
1.28
N/A
2.28
2.31
2.98
Information Ratio
0.1372
0.1451
(0.03)
0.044
(0.06)
(0.02)
(0.03)
0.0933
Value At Risk
(9.28)
(1.48)
(1.61)
(2.75)
(7.00)
(2.52)
(3.89)
(5.03)
Expected Short fall
(6.32)
(1.09)
(1.44)
(1.18)
N/A
(1.82)
(2.18)
(3.84)
Downside Deviation
5.3
1.01
1.28
1.42
N/A
2.89
2.35
3.6
Semi Variance
18.76
0.6003
0.8092
1.65
N/A
5.2
5.35
8.89

Omeros Competition Performance Charts

Five steps to successful analysis of Omeros Competition

Omeros' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Omeros in relation to its competition. Omeros' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Omeros in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Omeros' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Omeros, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Omeros position

In addition to having Omeros in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Israel Wall Street Thematic Idea Now

Israel Wall Street
Israel Wall Street Theme
Cross-sector collection of best publicly traded Israel entities that are expected to continue growing. The Israel Wall Street theme has 71 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Israel Wall Street Theme or any other thematic opportunities.
View All  Next Launch

Additional Information and Resources on Investing in Omeros Stock

When determining whether Omeros is a strong investment it is important to analyze Omeros' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Omeros' future performance. For an informed investment choice regarding Omeros Stock, refer to the following important reports:
How To Invest In Omeros
Details
Is Omeros Stock a good investment?
Details
What is Omeros' Net Worth?
Details
Largest Pharmaceuticals Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out Omeros Correlation with its peers.
For more detail on how to invest in Omeros Stock please use our How to Invest in Omeros guide.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Altman
Z Score
Details
Intrinsic
Valuation
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
Please note, there is a significant difference between Omeros' value and its price as these two are different measures arrived at by different means. Investors typically determine if Omeros is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omeros' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY